Vinculin anticorps (C-Term)

N° du produit ABIN926662

Cet anticorps Lapin Polyclonal détecte spécifiquement Vinculin dans WB. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Vinculin anticorps (C-Term) (ABIN926662)

Antigène: Vinculin (VCL)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Vinculin est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-Vinculin anticorps

Épitope: C-Term

Purification: Purified

Immunogène: VCL antibody was raised in rabbit using the C terminal of VCL as the immunogen

Information d'application

Indications d'application: Optimal conditions should be determined by the investigator.

Commentaires:

VCL Blocking Peptide, (ABIN5616950), is also available for use as a blocking control in assays to test for specificity of this VCL antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur Vinculin

Antigène: Vinculin (VCL)

Autre désignation: VCL

Sujet: Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. Synonyms: Polyclonal VCL antibody, Anti-VCL antibody, vinculin antibody, CMD1W antibody, CMH15 antibody, MVCL antibody.

Pathways: Cell-Cell Junction Organization, Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2